Clinical Trials
- Brain, Spinal Cord & Nervous System
The Brain Shuttle Study
- Brain, Spinal Cord & Nervous System
Identifying and Characterizing Preclinical MS
- Ages13 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS)
- Ages18 years - 55 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Multiple Sclerosis: Symptoms and Hormones Study
- Ages18 years - 45 years
- GenderFemale only
- Brain, Spinal Cord & Nervous System
Efficacy and Safety of ABC008 in Inclusion Body Myositis
- COVID-19 Inpatient, COVID-19 Outpatient
Patient response to COVID19 outbreak
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Evaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Immunologic Mechanisms in Neurological Diseases
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth